Health Innovation Euregion 2025

12 Jun 2025 | Netherlands

MosaMatrix BV

Company

Maastricht, Netherlands
7 profile visits

About

MosaMatrix has developed a new class of BioInks for 3D printing cells. They show execellent printability, cell survival and tissue maturation. The BioInk is easy to handle, allows the addition of peptide fragments and the biomechanics properties can vary over a broad ranges of stiffness and elasticity

THERAPEUTIC AREA

Cardiology/Vascular DiseasesDermatologyDiagnosticsHematologyHepatologyNephrologyNeurologyOncologyPharmacology/Toxicology

VALUE CHAIN

Components / Materials

MEDICINE

Medical BiomaterialsMedical Technology / Biomedical Engineering

Representatives

Jan Hunik

CEO

MosaMatrix BV